Medtronic Buys Spinal Cord Therapy Company, Adding To Its Chronic Pain Management Platform

Medtronic Buys Spinal Cord Therapy Company, Adding To Its Chronic Pain Management Platform

Source: 
Motley Fool
snippet: 

Top medical device maker and popular healthcare stock Medtronic (NYSE: MDT) is now one asset larger. The company announced late Wednesday night that it acquired Stimgenics, a privately held enterprise that focuses on cutting-edge spinal cord stimulation (SCS) technology to alleviate pain.